HPV Testing Evidence Examined In Cervical Cancer Screening Guidelines
This article was originally published in The Gray Sheet
The U.S. Preventive Services Task Force finds the evidence inconclusive for employing human papillomavirus testing as part of cervical cancer screening for women over 30, and it explicitly recommends against HPV testing in younger women.
You may also be interested in...
FDA Panel Supports Roche HPV Assay To Replace Pap As Primary Cervical Cancer Screen
The Microbiology Devices Panel provided unanimous support Roche’s submission to upgrade labeling for it cobas HPV test as a first-line, primary screen for cervical cancer.
New Products In Brief
Abbott earns approval in Japan for Xience Xpedition everolimus-eluting stent. Zimmer will distribute SpineCraft’s APEX system. More new product news.
News In Brief
Sanofi picks up Pluromed. Arriva Medical buys AmMed Direct. Sanuwave gives PMA status update. More news briefs.